Drug Type Small molecule drug |
Synonyms YTHDC1 inhibitor(Transition Bio) |
Target |
Action inhibitors |
Mechanism YTHDC1 inhibitors(YTH domain containing 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | United States | 27 Apr 2025 | |
Acute Myeloid Leukemia | Preclinical | United Kingdom | 27 Apr 2025 | |
Small Cell Lung Cancer | Preclinical | United States | 27 Apr 2025 | |
Small Cell Lung Cancer | Preclinical | United Kingdom | 27 Apr 2025 |